Inotuzumab Ozogamicin - PF-05208773
- Registration Number
- NCT03127605
- Lead Sponsor
- Pfizer
- Brief Summary
Inotuzumab Ozogamicin Expanded Access Program
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- APPROVED_FOR_MARKETING
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Exclusion Criteria
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method